Clinical Trials · NCT05708859
Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- Matthew J. Budoff
- Enrollment
- 120
- Start date
- Jan 2024
- Locations
- 1 site, United States
- Primary endpoint
- Reduction of total non-calcified coronary plaque volume